Cross Country Healthcare (NASDAQ:CCRN) Issues Earnings Results, Misses Estimates By $0.09 EPS

Cross Country Healthcare (NASDAQ:CCRN) released its earnings results on Wednesday. The business services provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.03 by ($0.09), FiscalAI reports. The firm had revenue of $236.76 million for the quarter, compared to the consensus estimate of $254.30 million. Cross Country Healthcare had a positive return on equity of 0.12% and a negative net margin of 9.00%. Cross Country Healthcare updated its Q1 2026 guidance to -0.060–0.040 EPS.

Here are the key takeaways from Cross Country Healthcare’s conference call:

• CEO Kevin Clark has refocused the company after the terminated merger and expects to “restore momentum,” targeting a year-end 2026 revenue run rate north of $1 billion and an Adjusted EBITDA margin of 4%–5%.
• Q4 revenue was $237M (down 24% YoY) and full-year revenue was $1.05B (down 22%), with a non‑cash impairment of $78M; Q1 guidance is $235–240M revenue and Adjusted EBITDA of $4–5M.
• The balance sheet is strong with about $109M cash and no debt, management is actively repurchasing shares and pursuing disciplined, accretive M&A opportunities.
• Management is pushing proprietary technology—Intellify and Xperience—into new markets (home-based, education) and investing in AI/ERP automation to improve speed-to-fill, efficiency, margins, and scalable recurring revenue.
• Operational actions include significant cost reductions (U.S. headcount down ~21%), a ~700–800 person India center of excellence, and redeploying savings to hire dozens of recruiters and account managers, with early weekly production trending up in 2026.

Cross Country Healthcare Stock Performance

Cross Country Healthcare stock opened at $9.89 on Friday. The stock has a 50-day simple moving average of $8.66 and a 200 day simple moving average of $10.76. The stock has a market capitalization of $324.00 million, a P/E ratio of -3.38, a PEG ratio of 6.71 and a beta of 0.42. Cross Country Healthcare has a 52 week low of $7.43 and a 52 week high of $16.84.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the business. Oxford Asset Management LLP acquired a new stake in shares of Cross Country Healthcare during the 4th quarter worth about $158,000. Lazard Asset Management LLC acquired a new stake in Cross Country Healthcare during the fourth quarter worth approximately $282,000. Intech Investment Management LLC boosted its holdings in shares of Cross Country Healthcare by 31.6% during the fourth quarter. Intech Investment Management LLC now owns 18,202 shares of the business services provider’s stock worth $147,000 after acquiring an additional 4,371 shares during the period. Brevan Howard Capital Management LP bought a new stake in shares of Cross Country Healthcare during the third quarter worth approximately $178,000. Finally, Brooklyn Investment Group increased its stake in shares of Cross Country Healthcare by 228.9% during the third quarter. Brooklyn Investment Group now owns 10,583 shares of the business services provider’s stock worth $150,000 after purchasing an additional 7,365 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. Jefferies Financial Group set a $8.65 target price on Cross Country Healthcare and gave the company a “hold” rating in a research note on Thursday, December 4th. Weiss Ratings reissued a “sell (e+)” rating on shares of Cross Country Healthcare in a research report on Monday, December 29th. Cross Research set a $14.00 target price on shares of Cross Country Healthcare in a research report on Thursday. Benchmark upgraded shares of Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $14.00 price target on the stock in a research note on Thursday. Finally, Zacks Research upgraded Cross Country Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, January 19th. Three equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $12.03.

About Cross Country Healthcare

Cross Country Healthcare, Inc, headquartered in Boca Raton, Florida, is a leading provider of healthcare workforce solutions in the United States. The company specializes in the recruitment, placement and management of nursing and allied health professionals on both a travel and permanent basis. Through its integrated platform, Cross Country Healthcare serves hospitals, health systems, and long-term care facilities by matching qualified clinical talent with patient care needs across diverse care settings.

The company’s core service offerings include travel nurse and allied health staffing, per diem staffing, permanent placement services, and managed services programs.